During infection with herpes simplex virus, infected-cell polypeptide 4 (ICP4) activates transcription of most herpes simplex virus genes. In the present study, the mechanism of activation of transcription by ICP4 was investigated by using a reconstituted in vitro system with fractionated and purified general transcription factors, coupled with DNA-binding assays. The templates used in the reactions included regions of the gC and thymidine kinase (tk) by an inserted site that normally acts to repress transcription, or by the addition of sufficient non-sitecontaining DNA. The gC TATA box and start site, or initiator element (inr), were individually sufficient for activation by ICP4 and together contributed to optimal activation. In contrast to gC, the tk promoter was poorly activated in the reconstituted system. However, the tk TATA box was efficiently activated when the tk start site region was replaced with the gC inr, suggesting that activation was mediated through the inr and inr-binding proteins. In addition, mutation of the inr core resulted in a gC promoter that was very poorly activated by ICP4. The results of this and previous studies demonstrate that ICP4 activates transcription in a complex manner involving contacts with DNA 3' to the start site, TBP, TFIIB, TBP-associated factors, and possibly proteins functioning at the start site of transcription.
During infection with herpes simplex virus, infected-cell polypeptide 4 (ICP4) activates transcription of most herpes simplex virus genes. In the present study, the mechanism of activation of transcription by ICP4 was investigated by using a reconstituted in vitro system with fractionated and purified general transcription factors, coupled with DNA-binding assays. The templates used in the reactions included regions of the gC and thymidine kinase (tk) promoters in plasmids, and on isolated fragments, allowing for the evaluation of the potential function of naturally occurring and inserted ICP4-binding sites and elements of the core promoter. ICP4 efficiently activated transcription of the gC promoter by facilitating the formation of transcription initiation complexes. ICP4 could not substitute for any of the basal transcription factors. Moreover, TATA-binding protein (TBP) could not substitute for TFIID in activation, suggesting a requirement for TBP-associated factors. Interactions between ICP4 and DNA 3' to the start site was necessary for activation of the gC promoter. The requirement for DNA-protein contacts could be met either by the presence of an ICP4-binding site in the gC leader, by the presence of a site more than 150 nucleotides further downstream, by an inserted site that normally acts to repress transcription, or by the addition of sufficient non-sitecontaining DNA. The gC TATA box and start site, or initiator element (inr), were individually sufficient for activation by ICP4 and together contributed to optimal activation. In contrast to gC, the tk promoter was poorly activated in the reconstituted system. However, the tk TATA box was efficiently activated when the tk start site region was replaced with the gC inr, suggesting that activation was mediated through the inr and inr-binding proteins. In addition, mutation of the inr core resulted in a gC promoter that was very poorly activated by ICP4. The results of this and previous studies demonstrate that ICP4 activates transcription in a complex manner involving contacts with DNA 3' to the start site, TBP, TFIIB, TBP-associated factors, and possibly proteins functioning at the start site of transcription.
Herpes simplex virus (HSV) contains a 152-kb doublestranded DNA genome encoding approximately 75 genes (45, 46) . Early in infection, five of these genes, termed immediateearly (IE) or a genes (32) , are efficiently transcribed (82) partly as a result of the transcriptional activation function of VP16 (7) , which is brought in with the infecting virion (2, 59) . The products of the IE genes function at different levels and at different times in the viral life cycle to achieve the efficient and regulated expression of the remainder of the viral genome (9, 33, 81) . These are infected-cell polypeptide 4 (ICP4), ICPO, ICP27, ICP22, and ICP47 (9, 32, 57, 82) . Of these, ICP4 is essential for the growth of herpes simplex virus because it activates transcription of most of the essential genes of the virus (13, 14, 19, 21, 24, 52, 60, 62, 81) . In the absence of ICP4, the accumulation of viral early and late mRNA ranges from undetectable to several percent of that seen in the presence of ICP4 (16, 35, 36) . ICP4 can also function as a transcriptional repressor, most notably acting to repress transcription of its own promoter (14, 26, 49, 53, 64, 65) .
ICP4 is a 175-kDa phosphoprotein (11, 57) that localizes mostly in the nucleus (11) and exists in solution as a homodimer (48, 72) . Genetic and biochemical studies of ICP4 have demonstrated that ICP4 is composed of discrete functional domains including DNA-binding, dimerization, nuclear localization, and transcription activation regions (16, 54, 55, 71) , which collectively function to produce the transcriptional profile seen in infected cells. ICP4 has a specific DNA-binding activity, recognizing a very degenerate consensus sequence (17, 23, 41, 50, 51) . The specific DNA-binding activity is important for repression of transcription in vivo and in vitro (26, 49, 65) and may also be involved in the temporal regulation of some viral genes, repressing transcription prior to viral DNA synthesis (40, 64) . With few exceptions (37, 56, 70) , most mutations in ICP4 that reduce its ability to specifically bind to DNA also reduce its ability to repress and activate transcription (55, 71) . However, several previous studies have been unable to demonstrate that any specific sequence or ICP4-binding site(s) is necessary for activation in HSV-infected or transfected cells (10, 20, 22, 28) .
ICP4 and the pseudorabies virus 180-kDa IE protein are functional analogs that possess regions of amino acid conservation (8) , and both have been shown to activate transcription in vitro (1, 3) . Pizer and colleagues (78) have proposed that ICP4-binding sites in the vicinity of the gD promoter facilitate activation by ICP4; however, the same binding sites are completely dispensable in the context of the viral genome (75) . This led to the hypothesis that ICP4 can activate transcription through any one of the numerous ICP4-binding sites present in the HSV genome, despite the relatively low affinity of ICP4 for most of these sites. The results presented in this study test the above hypothesis as well as the absolute need for specific ICP4-binding sites in transcriptional activation.
Each of the HSV genes has its own promoter that is recognized by cellular RNA polymerase II, and almost all the promoters contain a TATA box, which is recognized by TATA-binding protein (TBP) (30, 39, 58) . For the specific initiation of transcription, RNA polymerase II requires a number of other proteins termed general, or basal, transcription factors (44, 67) . These include TFIID, TFIIB, TFIIE/F, TFIIA, TFIIH, and TFFIIJ (5) . TFIID exists in cells as a complex containing TBP and TBP-associated factors (TAFs) (85) , which have been shown to be important for the function of many activator proteins (4, 79) . The sequential interaction and assembly of the general transcription factors to form an initiation complex on the promoter is believed to start with the binding of TBP to the TATA box (6) . It has previously been shown that ICP4 can form a tripartite complex with TBP and TFIIB on DNA and that this interaction is mediated through a region of ICP4 that is important for activation (76) . In addition to the TATA box, many core promoters contain an important element located around the start site of transcription, termed an initiator (inr) element (74, 84) . This element can function in the absence of the TATA box to promote the site-specific initiation of transcription. The best-studied initiator is that for TATA-less terminal deoxynucleotidyl transferase (TdT) promoter, having the core sequence -3 CTCA + 1 (74) . The experiments in this study address the general requirements of TAFs for activation by ICP4 and the importance of the start site region, or inr element.
To investigate the mechanism of ICP4 activation and address the questions raised above, we reconstituted in vitro transcription with fractionated general transcription factors from HeLa cells and purified TFIIB, TBP, and ICP4 and templates containing the gC and thymidine kinase (tk) promoters. The promoters for gC (31, 83) and tk (10, 38, 47) have been extensively studied in intact cells, and while gC and tk differ with respect to the presence of functional cis sites for cellular factors upstream of the TATA box, both can be activated by ICP4 as a sole consequence of the TATA box (31, 35, 36) . This study investigates the mechanism of and parameters for ICP4 to activate these core promoters in vitro.
MATERMILS AND METHODS
Construction of template plasmids. Plasmid pgCL contains the gC promoter sequences from -35 to + 124 relative to the transcription start site. The construction of pgCL is described below in greater detail, and other promoter-containing plasmids used in this study were made by the same strategy. The SmaI (-35)-NntI (+124) fragment of the gC promoter region was cloned into the BamHI-BglII sites of p-111/-32HB after the ends were made blunt with the Klenow fragment of Escherichia coli polymerase and converted with synthetic linkers to BamHI and BglII sites, respectively. p-111/-32HB is a pUC18 derivative consisting of a HindIll (-500)-BglII (+55) fragment of HSV-1 tk promoter region that also has a BamHI restriction site to replace sequences between -111 and -32 (36) . Thus, the BamHI-BglII-digested vector portion of p-111/ -32HB lacks tk promoter sequences and was used to clone in the gC promoter and its derivatives. The HindIII-BglII fragment contained in the tk-gC hybrid HB plasmid was then used to replace the HindIII and BglII fragment in pLSWT. pLSWT contains the HSV sequence from -500 relative to the start of tk transcription to the BamHI site 2.86 kb downstream of the tk start site (36 and then into pLSWT to give rise to p46gC. p46gCm was made with the same oligonucleotides except that there is a single C-to-G change at the indicated position. In the same way, a similar construct containing. the tk TATA box and the gC start site region ptk-gC was constructed with the oligonucleotides 5'GATCCGGTTCGCATATTAAGGTGAAGGGGACACG GGCTACCCTCACTA3' and 5'GATCTAGT%3AGGGTAG CCCGTGTCCCCTTCACCITTAATATGCGAACCG3'. To make a template containing the gC TATA box and the tk start site region, the oligonucleotides 5'GATCCGGGGTATAAA TTCCGGA3' and 5'CGCGTCCGGAATT'ATACCCCG3'
were annealed and cloned into the BamHI (-111) and MIuI (-11) sites of p-111/-32HB and then into pLSWT as described above.
Several plasmids with 3' deletions of the gC leader were generated, from which the templates in Fig. 5 HindIll-and BglII-digested pLSWT. Individual deletion mutant isolates were sequenced to determine the deletion end point in the leader sequence.
To make gC TATA box deletion plasmids, the HB derivatives of p46gC and p46gCm DNA were digested with BamHI (-35) and BspEI (-20) and treated with the Klenow fragment of E. coli DNA polymerase to fill in the overhangs. After blunt-end ligation the BamHI restriction site was regenerated, and the resulting plasmid had a net deletion of 13 bp including the gC TATA box (CGGGGTATAAATT). The tk promoter upstream sequences from -500 (HindIII) to -32 (BamHI) were used to replace the HindIII-BamHI fragment from the above plasmid to position the Spl-and CAAT-binding sites normally upstream of the tk promoter, upstream of the gC start site region. The constructs were then put into pLSWT as described above.
To clone the high-affinity ICP4 binding-site sequence from the ICP4 promoter into gC-containing plasmids, the oligonucleotides 5'GATCCGCCCCGATCGTCCACACGGAGCGC G3' and 5'GATCCGCGCTCCGTGTGGACGATCGGGGC G3' (the ICP4-binding consensus sequence is underlined) were annealed and ligated into the unique BglII site downstream of the transcription start in the pLSWT derivatives (at +48 in templates 9 and 10 of Fig. 5 ). Mutant 27-mer oligonucleotides, lacking ATC in the above sequences, were also used to generate control plasmids that gave rise to templates 8 and 12 in Fig. 5 . DNA fragments used as templates in the transcription studies were generated with restriction enzymes and purified from 4% native polyacrylamide gels by electroelution and Sephadex G-50 chromatography.
J. VIROL. Cells and viruses. HeLa cells were grown in suspension in minimal essential medium (Gibco) supplemented with 10% fetal bovine serum and used to make the general transcription factor fractions. The procedures for growth and maintenance of HSV in Vero or E5 cells have been described previously (13) . HSV KOS was used as the initial source of ICP4. E5 cells are a transformed Vero cell line that express complementing levels of ICP4 (15) . n12 is a mutant HSV strain that contains a nonsense mutation in ICP4 that specifies no ICP4 activity and can be propagated on E5 cells (16) . The n12 derivative virus harboring the gCL-tk chimera at the tk locus on which the primer extension analysis was carried out (see Fig. 1C ) was provided by Ramon Rivera-Gonzalez and will be described elsewhere.
Preparation of general transcription factors, TBP, TFIIB, and ICP4. HeLa cell suspension (80 liters) was used to make nuclear extracts by the method of Dignam et al. (18) . Fractionation of the general transcription factors from the nuclear extract was performed by the methods of Reinberg and Roeder (63) and Lin and Green (43) as modified by Gu et al. (26) . The designations of the phosphocellulose and DEAE-Sephacel fractions were as previously described (26) . The bacterial expression and purification of human rTBP (39) and rTFIIB (27) were performed as described by the respective authors with minor modifications (36) . Wild-type ICP4 and the deletion mutant X25 were purified from KOS-and X25-infected cells, respectively, as previously described (69, 72) .
In vitro transcription reactions. Final conditions for the in vitro transcription reactions were 40 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.9); 60 mM KCl; 12% glycerol; 8.3 mM MgCl2; 0.6 mM (each) ATP, CTP, GTP, and UTP; 0.3 mM dithiothreitol; and 12 U of RNasin; they have been described previously (26) . The concentration of template DNA was 0.5 pmollml (0.08 ,ug of a 7.5-kb plasmid in a 30-,u reaction volume), except for the experiment in Fig. 2 , for which the indicated amounts of DNA were used. The amounts of the individual transcription factors used in the reactions were 0.5 ,u of AB (TFIIA), 6 RI of CB (TFIIE/F), 4 pI of CC (polymerase II), 0.5 plI of rTFIIB, and 5 ,u of DB (TFIID). A 1-pA portion of ICP4 (0.1 ,ug/pA) was added to the transcription reaction mixtures after the mixing of the general factors and before the addition of the remaining components described above. After incubation of the transcription reaction mixtures at 30°C for 80 min, the synthesized RNAs were extracted twice with phenol and precipitated with ethanol. The conditions for primer extension reactions were as previously described (35) . After phenol extraction and ethanol precipitation, the reverse transcription products were separated on 5% denaturing polyacrylamide gels. Autoradiographic images of the gels were established by exposing the dried gel to XAR films, and the signals were quantified by using a GS 300 scanning densitometer.
Gel mobility shift assays. DNA-binding reactions with endlabeled DNA probes and purified ICP4 were carried out in a total volume of 30 pl. The buffer consisted of 10 mM HEPES (pH 7.9), 5 mM ammonium sulfate, 8% (vol/vol) glycerol, 2%
(wt/vol) polyethylene glycol 6000, 50 mM KCI, 5 mM P-mercaptoethanol, 0.2 mM EDTA, and 25 jig of poly(dGC) per ml. When monoclonal antibody against ICP4 was used, 1 ,ul of a 1/10 dilution of 58S (73) was added simultaneously to the reaction mixture. The reaction mixtures were incubated at 30°C for 30 min, and the products were separated at 200 V on a native 4% polyacrylamide gel containing 0.5 x Tris-borate-EDTA (TBE). The gel was then dried and exposed to XAR S film. conducting comparative in vivo experiments and also to permit analysis of gC-tk chimeric promoters. The experiments described below address the transcription factor requirements and kinetic parameters for activation by ICP4, the role of ICP4 DNA binding, and the contributions of the TATA box and inr to activation in vitro.
ICP4 activates transcription from the gC promoter in vitro. Fractionated HeLa cell nuclear extracts were used as the source of basal transcription factors along with purified recombinant human TFIIB made in E. coli. After basal transcription had been reconstituted with the cellular factors by using an intact plasmid containing the gC promoter as template (pgCL), purified ICP4 from wild-type-virus-infected cells was added to the transcription mixture. ICP4 strongly activated transcription from the gC promoter in a concentration-dependent manner (Fig. 1B) . Activation was observed on the addition of as few as two dimer molecules of ICP4 per template. There was a sharp increase in transcription, up to 20-fold, with the addition of between 2 and 10 ICP4 dimers per template, with saturation occurring at higher levels of ICP4. To confirm that the activation of transcription from the gC promoter was specifically a function of the activity of ICP4, polyclonal serum against ICP4 was included in the transcription reactions (Fig.  1C) . In the absence of ICP4, the amount of serum used in the reactions had little effect on basal transcription; however, activation was almost completely abrogated by inclusion of the antibody. Lastly, the transcription start sites of the gCL template in vitro and in the context of viral infection were compared. The gC-tk chimeric construct gCL was inserted into the n12 HSV genome, which does not express a functional ICP4 (16) . As a consequence, primer extension signals were obtained from RNA isolated only from infected ICP4-producing cells (E5) but not from its parent cell (Vero), demonstrating that ICP4 activated transcription in vivo as it did in the in vitro transcription experiments (Fig. 1D) . Moreover, the primer extension products obtained from in vitro transcribed RNA were the same as those obtained from the RNA isolated from infected cells. These results document the authenticity of the in vitro experiments with respect to induction by ICP4 as well as for the start of transcription.
Kinetic parameters for activation of the gC promoter by ICP4. The effect of template concentration and nonspecific competitor DNA on the ability of ICP4 to activate transcription was assessed first. Increasing the amount of template DNA could potentially drive the formation of preinitiation complexes or titrate out molecules that act to repress transcription, thereby bypassing the requirement for ICP4 to achieve high levels of transcription and operationally reducing its effectiveness. Consistent with this hypothesis, significantly higher levels of transcription were achieved when a fivefoldhigher concentration of gC template DNA was used ( Fig. 2A) To test the hypothesis that ICP4 acts to promote the formation of initiation complexes, the experiment outlined in Fig. 2B was performed. Template and basal transcription factors were incubated for different lengths of time in the absence and presence of ICP4. At the different times, the formation of additional initiation complexes was inhibited by the addition of Sarkosyl, and elongation was then allowed to proceed for an additional 80 min. It has been shown that low concentrations of Sarkosyl inhibit the formation of transcription initiation complexes but that elongation of a committed transcription complex is unaffected (29) . Therefore, the quantity of primer extension product is a measurement of the number of transcription initiation complexes formed in the time interval prior to the addition of Sarkosyl. Figure 2B and C shows the primer extension products observed and their quantitative representation, respectively. In the absence of ICP4, the level of transcription increased very slowly with time and remained relatively low even after prolonged incubation, indicating that transcription initiation complexes formed slowly. In the presence of ICP4, the transcription signal was easily detected at the early time points and the level of signal increased at a much greater rate than in the absence of ICP4. These results indicate that ICP4 induces transcription by increasing the rate of transcription initiation complex formation and hence the number of complexes formed at a given time. This conclusion is consistent with that previously made for the action of ICP4 in nuclear extracts on the gD promoter (3) .
Transcription factor and ICP4 domain requirements for activation. If ICP4 acts at a stage in the formation of initiation complexes, it is conceivable that it may substitute for one or more of the general factors. To address this possibility, transcription reactions were conducted in the presence and absence of ICP4, with each of the different general transcription fractions omitted (Fig. 3A) . Similar to what we have previously observed with the ICP4 promoter (26) , transcription from the gC promoter in the absence of the TFIIA fraction yielded similar levels of transcripts to those seen in the presence of TFIIA fraction, indicating that the TFIIA fraction (AB) was not absolutely necessary in our in vitro transcription reactions. When omitted, the CC fraction, which contains RNA polymerase II, resulted in only a partial decrease in transcription, possibly because of its presence in the CB fraction as well. When the TFIIE/F fraction (CB) was omitted, a significant decrease in the transcription signal was observed. CC fraction contains trace amounts of TFIIE/F, which would account for the low-level transcription seen in the absence of CB. When either the DB (TFIID) fraction or rTFIIB was omitted, no transcription signals were detected. The same factor dependence was also seen in the absence of ICP4, although the absolute level of transcription was lower (sixth to eleventh lanes from left). The data indicated that the TFIID, TFIIE/F, and TFIIB fractions were all required to achieve full ICP4-activated transcription. The DB fraction contains TFIID, which is a multiprotein complex composed of TBP and 5 to 10 TAFs. Many transcriptional activators require TAFs in TFIID for transcriptional activation, as operationally defined by the inability of TBP alone to support activated transcription. Figure 3A shows that ICP4 also requires TAFs, since activation did not occur when rTBP was substituted for TFIID.
Transcriptional activator proteins often contain domains that communicate with basal factors and/or TAFs to activate transcription. We have previously shown that a mutant ICP4 protein, termed X25 (72), which retains the ability to bind to DNA but lacks the domains required for activation in the context of viral infection (71, 72) , also does not form complexes with TBP and TFIIB on DNA (76) . Consistent with in vivo results, X25 failed to activate transcription (Fig. 3B) (Fig. 1A) and used as templates in transcription reactions in the presence and absence of ICP4 (Fig. 4B) (Fig. 5) and purifying the resulting promoter-containing fragments from polyacrylamide gels. Transcription from the fragment containing the whole gC leader sequence (template 1) was efficiently activated by ICP4, as was transcription from template 2, albeit to a lesser extent (Fig. 5) . Template 2 is deleted for sequences between +85 and + 124. However, templates 3 and 4, which are deleted for sequences between +48 and + 124 and between +5 and + 124, respectively, were not activated by ICP4. These data indicate that there is an important cis site for activation located between +48 and +85 and that deletion of this region in the leader is compensated for by other sites provided in cis in the intact plasmid template (Fig. 4A) . To address this possibility, templates that are deleted between +5 and + 124 and that have increasing extents of DNA downstream of the MluI site were prepared and tested in vitro. When DNA downstream of the MluI site was appended to the template, activation was restored (templates 5 and 6). Moreover, the level of activation increased with increasing extents of DNA downstream of the Mlul site. Therefore, the deletion of DNA possibly containing specific sites for activation can be compensated for by the presence of distally located sites, or ICP4 may just require a certain linear extent of DNA to function, independent of specific binding sites.
ICP4 has a remarkably degenerate binding-site consensus that has been summarized to be, roughly, RTCGTCNNY NYSG (R = purine; N = A, T, C, or G; Y = pyrimidine; and S = G or C) (17) . Therefore, it is possible that such sites exist in the regions found to be important for activation in the above experiments. Indeed, a site having the sequence GTGGLTC CGIGITG has been previously described in the region between +48 and +85 (17 The AATC-binding-site mutant does not bind ICP4 and is nonfunctional as a repressor site (16, 64) . Since the primer used for reverse transcription locates 3' to the gC leader, the primer extension products obtained from some of the deletion templates are different in size (Fig.  4) . For ease of representation, the regions of signal for templates 1 to 3 were cut from the same gel and pasted alongside each other. The presence and absence of ICP4 in the reactions are indicated by + and -, respectively. The restriction sites are those indicated in Fig. 1 . studies showed that a probe containing the whole gC promoter and leader sequence from -35 to + 124 was bound by ICP4 (data not shown). An analogous probe with the sequences between +85 and + 124 deleted was also bound by ICP4, whereas the probe deleted for the sequence between +48 and + 124 failed to bind ICP4 (Fig. 6) . The existence of this site is consistent with the previous report mentioned above and also represents a positive correlation with the functional data for these templates. Since it was found that sequences downstream of the MluI site could compensate for the deletion of the leader sequence for activation, the existence of ICP4-binding sites in this region was investigated. The results in Fig. 6 show that there is a specific ICP4-binding site present between the SplI and EcoRV sites, reaffirming an apparent correlation between the presence of an ICP4-binding site in a template and the ability of the template to be activated by ICP4.
Given the apparent correlation between the ability of ICP4 to activate a template and the presence of an ICP4-binding site, we investigated the possibility that the addition of a strong ICP4-binding site to a template that was not activated by ICP4 would result in activation. The relatively strong ICP4-binding sequence from the start site of the ICP4 promoter region (23, 41, 51) was introduced into template 3 at the BglII site in both orientations as a 30-mer oligonucleotide (Fig. 5, templates 9 and 10). This site is normally responsible for autorepression of the ICP4 promoter in transient expression assays, in the viral genome, and in vitro (26, 49, 64, 65 Role of the start site region and TATA bo ICP4-activated transcription. Preliminary in tion results showed that the gC promoter was than the tk TATA box promoter for basal tr, was activated to a greater extent by ICP4. Th difference was investigated by conducting tran iments with several chimeric promoters betwee sequences. The chimeric promoters paired the and TATA box of the two promoters. The designated for the TATA box/start site region t are shown in Fig. 7A . The indicated template transcription reactions, and the primer extenm tained in these reactions were quantified by densitometry (Fig.   7B ). The tk TATA box was approximately 10- (Fig. 8A) . The sequence of the gC start site region is similar to that of TdT in the region designated to be an initiator, whereas the tk start site region differs. Of note is _ L the sequence CTCA, often considered to be the core of the inr / t k, region (84) . To test the significance of this region with respect to its contribution to basal and activated transcription, the indicated C residue in p46gC (Fig. 8A) was changed to a G rs differently. (A) residue to produce the template, p46gCm. In transcription gC-tk hybrids are assays with p46gCm, the levels of basal and ICP4-activated he junction of the transcription were decreased (Fig. 8B) . There was also a subtle and light-shaded effect on the position of the measured transcription start site.
The transcription The net level of activation by ICP4 of p46gCm was approxi-3) Quantitation of mately 2.5-fold, a situation similar to that for tk (Fig. 7B) Lnt site did not observed with the TATA box deletions and fractionated facn). However, in tors (data not shown). Accordingly, the tk upstream region was d, transcription appended to the promoters and nuclear extracts were used as af ICP4 (Fig. 5 ).
a source of factors. The intact gC promoter consisting of the -nting an exper-TATA box and the inr gave measurable levels of basal 12. The reason transcription and substantial levels of ICP4-activated transcrip-1 12 are approxtion; however, the TATA-less template also produced detectmobility of the able signal in the presence of ICP4 (Fig. 8C) . Transcription in the specific gC the presence of ICP4 was not observed from the TATA-less nts, template 11 promoter when the initiator was mutated by the single C-to-G as activated by change. Therefore, given the sequence similarity of the gC start site region of the TdT inr, the ability of the gC start site region x in basal and to allow accurate transcription in the absence of the TATA vitro transcripbox, and the observation that a single-base-pair change within much stronger the start site region can abrogate transcriptional activity in the anscription and absence of the TATA box (Fig. 8C) , this region of gC may be ie basis for this considered an initiator. Moreover, ICP4 can activate transcripscription expertion as a function of the inr, independently of the TATA box. n the gC and tk start site region DISCUSSION templates are hey contain and
The experiments in this study document the authentic -s were used in reconstruction of the activation of the gC promoter by ICP4 in sion signals obvitro with fractionated HeLa nuclear factors. ICP4 efficiently activated the gC promoter, giving rise to start sites that were indistinguishable from those observed in the context of viral infection. Activation occurred by facilitating the formation of initiation complexes on the gC promoter and/or by relieving repression. This was inferred by allowing complexes to form in the presence and absence of ICP4 without allowing elongation and then inhibiting further complex formation and allowing the elongation from the preformed initiation complexes. While the approach and quantitative aspects differ, these results are in agreement with previously reported data (1, 3) . However, in contrast to previous results (1), the inclusion of nonpromoter DNA in the reaction did not bypass the requirement for ICP4. This implies that ICP4 not only can relieve the negative effects of nonspecific repressor molecules but also can directly activate transcription by facilitating the formation of initiation complexes. Lastly, an ICP4 mutant protein that retains its ability to dimerize and bind to DNA but does not activate transcription in infected cells (71, 72) was also unable to activate transcription in vitro. Therefore, ICP4 was able to truly activate transcription in a manner consistent with its activity inferred from genetic experiments in intact cells.
By using fractionated factors, it was possible to infer that ICP4 does not eliminate the requirement for any individual general transcription factor. Therefore, the function of ICP4 is to augment the activity of these factors and not to functionally replace them. Additionally, when TBP was substituted for TFIID in the reactions, basal transcription occurred, which was not activated by ICP4. This result suggests that like many other activator proteins, such as Spl (61) and VP16 (86), ICP4 requires the TAFs for activation. It has also been previously shown that ICP4 will not function in its repressor mode when TBP is substituted for TFIID (26) , again indicating the importance of TAFs for ICP4 function. Given that ICP4 has been shown to form tripartite complexes on DNA with TBP and TFIIB and that the presence of ICP4 will lower the amount of TBP needed to detect occupancy of the TATA box (76) , these results present an apparent paradox that is not unique to ICP4. ElA (34, 42) and VP16 (43, 77) have been shown to interact with TBP and with TBP and TFIIB, respectively, yet, as mentioned above, both require TAFs for activation (25, 86) . It is possible that the interactions observed in vitro are not strong enough to be functionally significant on their own and that additional interactions with TAFs are necessary or that initiation complexes formed in the absence of TAFs are not in the proper conformation to allow activation to occur. It has been shown that VP16 interacts in a functionally significant way with a 40-kDa TAF, suggesting that activation is mediated through interactions with multiple proteins in the initiation complex (25, 79 (10, 20, 22, 28) . On the other hand, most mutations in ICP4 that eliminate VOL. 68, 1994 its DNA-binding activity interfere with activation (55, 71 Fig. 4 and 5 directly address this hypothesis. Figure 4 shows that (i) activation occurs independently of sequences upstream of the TATA box, and (ii) the gC leader region, which contains an ICP4-binding site, is dispensable for activation in an intact plasmid template. Figure 5 shows that (i) in contrast to the results of Fig. 4 Role of the core promoter in activation by ICP4. This study also examined the contribution of elements in the core promoter for activation by ICP4. These studies were precipitated by comparative in vitro transcription analysis of the tk and gC promoters. The proximal tk promoter was found to be relatively weak in vitro compared with the core gC promoter and was also inefficiently activated by ICP4 (Fig. 7) . The use of chimeric promoters exchanging gC and tk start site regions and TATA boxes revealed that, as previously shown, the gC TATA box is more efficient than the tk TATA box (36) (10) . Perhaps the factor(s) that functions through this region is missing in the reconstituted system to achieve full activation.
For activation of the gC promoter in vitro, ICP4 requires contacts with DNA. It has been shown previously that ICP4 is capable of interacting in a complex with TBP, TFIIB, and DNA and that a region important for this interaction is also involved in transactivation (76) . Additionally, TAFs are required for activation, suggesting that ICP4 interacts with one or more of these proteins. Lastly, given that the sequence of the start site region is also important for full activation by ICP4, it is reasonable to propose that inr-binding proteins may also functionally interact with ICP4. ICP4 is a large and genetically and structurally complex protein. It is likely that it functions via contacts with many of the proteins that make up the initiation complex. Additional studies examining the potential interactions between specific TAFs, inr-binding pro-teins, andICP4, as well as studies to elucidate the nature of the initiation complex in the presence of ICP4, are necessary before we fully understand how this complex protein activates transcription.
